OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9480	Companies
185559	Keywords
117951	Articles
99390	Press releases

Home
Companies
OXURION

BRIEF

published on 01/20/2025 at 18:05, 10 months 16 days ago

Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC

Acquisition D'actions Oxurion Opportunités Spéciales Atlas Avis De Transparence Thérapies Pour Les Maladies De La Rétine
PRESS RELEASE

published on 01/20/2025 at 18:00, 10 months 16 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV receives transparency notification regarding shares ownership from Atlas Special Opportunities, LLC, crossing the 20% threshold. Company engaged in developing ophthalmic therapies

Transparency Notification Ophthalmic Therapies Oxurion NV Shares Ownership Belgian Transparency Legislation
PRESS RELEASE

published on 01/20/2025 at 18:00, 10 months 16 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC
Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC over aankoop aandelen, voldoet aan Belgische transparantiewetgeving. Oogheelkundig bedrijf gevestigd in Leuven, België

Transparantiekennisgeving Oxurion NV Biofarmaceutisch Netvliesaandoeningen Belgische Transparantiewetgeving
BRIEF

published on 01/14/2025 at 18:05, 10 months 22 days ago

Oxurion reçoit une mise à jour de transparence d'Atlas Special Opportunities LLC

Actions Atlas Transparence Biopharmaceutique Oxurion
BRIEF

published on 01/14/2025 at 18:05, 10 months 22 days ago

Oxurion Receives Transparency Update from Atlas Special Opportunities LLC

Actions Transparency Atlas Biopharmaceutical Oxurion
PRESS RELEASE

published on 01/14/2025 at 18:00, 10 months 22 days ago

Oxurion ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities LLC
Oxurion NV ontvangt aangepaste transparantiekennisgeving van Atlas Special Opportunities LLC wegens verkoop van aandelen. Leuven biofarmaceutisch bedrijf actief in oftalmologische therapieën

Transparantiekennisgeving Oxurion NV Biofarmaceutisch Oftalmologische Therapieën België
PRESS RELEASE

published on 01/14/2025 at 18:00, 10 months 22 days ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities LLC
Oxurion NV announces receiving an amended transparency notification regarding share ownership by Atlas Special Opportunities, LLC, crossing under the 3% threshold

Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Retinal Disease
BRIEF

published on 01/13/2025 at 18:05, 10 months 23 days ago

Oxurion Updates Voting Rights Following Convertible Bond Conversion

Voting Rights Convertible Bonds Capital Increase Market Opportunities Oxurion
BRIEF

published on 01/13/2025 at 18:05, 10 months 23 days ago

Oxurion met à jour ses droits de vote suite à la conversion des obligations convertibles

Obligations Convertibles Augmentation De Capital Droit De Vote Opportunités De Marché Oxurion
PRESS RELEASE

published on 01/13/2025 at 18:00, 10 months 23 days ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converted 4 convertible bonds in Oxurion, leading to a EUR 100,000 capital increase. Oxurion focuses on developing vision-preserving therapeutics for the elderly

Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Elderly Vision

Accesswire

Published on 12/05/2025 at 21:45, 42 minutes ago

When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 57 minutes ago

The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 1 hour 7 minutes ago

Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 21:00, 1 hour 27 minutes ago

The Repricing Event: Why Multiple Global Industries Are Suddenly Moving Toward SMX
Published on 12/05/2025 at 20:25, 2 hours 2 minutes ago

The Feedback Loop: Why SMX's Adoption in One Industry Accelerates Interest in All the Others

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 22:15, 12 minutes ago

CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 15 minutes ago

EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 3 hours 29 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 4 hours 1 minute ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 4 hours 12 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd

Les Echos

Published on 12/05/2025 at 17:18, 5 hours 9 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 5 hours 9 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 7 hours 16 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 7 hours 16 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 8 hours 29 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE